Apelin, a promising target for type 2 diabetes treatment?
- 1 May 2012
- journal article
- review article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 23 (5), 234-241
- https://doi.org/10.1016/j.tem.2012.02.005
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant MiceDiabetes, 2012
- New insights into insulin resistance in the diabetic heartTrends in Endocrinology & Metabolism, 2011
- Apelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent MechanismsEndocrinology, 2011
- Apelin is necessary for the maintenance of insulin sensitivityAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- The hepatic apelin system: A new therapeutic target for liver diseaseHepatology, 2008
- Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.Acta Endocrinologica, 2008
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesisThe EMBO Journal, 2008
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998